Craig-Hallum Starts Actuate Therapeutics (ACTU) at Buy

April 22, 2025 7:25 AM EDT Send to a Friend
(Updated - April 22, 2025 9:02 AM EDT)

Craig-Hallum analyst Albert Lowe initiates coverage on Actuate Therapeutics (NASDAQ: ACTU) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login